DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 1 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,486,383 | +42.7% | 447,138 | +38.8% | 0.00% | +100.0% |
| Q2 2023 | $3,845,731 | +41.9% | 322,088 | +58.9% | 0.00% | 0.0% |
| Q1 2023 | $2,709,658 | -38.2% | 202,667 | -0.6% | 0.00% | 0.0% |
| Q4 2022 | $4,388,036 | +10.1% | 203,905 | +2.5% | 0.00% | 0.0% |
| Q3 2022 | $3,986,000 | +45.5% | 198,952 | +30.0% | 0.00% | 0.0% |
| Q2 2022 | $2,740,000 | +165.2% | 153,043 | +47.1% | 0.00% | – |
| Q1 2022 | $1,033,000 | -19.5% | 104,034 | +36.6% | 0.00% | – |
| Q4 2021 | $1,284,000 | -28.1% | 76,168 | +1.3% | 0.00% | -100.0% |
| Q3 2021 | $1,786,000 | – | 75,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
| PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
| Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
| RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
| COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
| Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
| Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
| Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
| Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |